Generic pharma sales and marketing company wanted in Europe

Company to buy

• Size: mid-sized or large company
• Revenue: 5-25M EUR
• Location of the target: Europe
• Reason for acquisition: The management of the buyer decided to grow through acquisitions
• #CFIE PHB013

Overview of this generic pharma sales and marketing company wanted

One of the leading world manufacturers of APIs is exploring the pharmaceutical market for an acquisition target of a mid-sized going concern in generic pharma space. The target they are looking for must have its own dossiers / MAs. The buyer is looking at Europe and the UK. As the company is successful, the acquisition can start after a suiting target occurs, funding is ready.

Profile (strategy) of this buyer for a generic pharma company in Europe

The buyer is a large Asian pharma company with almost 60 years of history and global presence. The company is operating globally with exports to more than 100 countries. The buyer has its own manufacturing set up in API to finished dosage formulations. Currently, the buyer is expanding in the area of Generics in UK and EU zone.

The company is well-established in the Asian continent but has diverse client portfolio with customers from Africa, Asia, Australia, Europe, and the US.

The company is focused on manufacture and sales of

• Generic pharmaceuticals
• APIs
• Formulations

The company is particularly strong in the anti-malaricals market. The company is becoming one of the largest formulation exporters from the Asian region. The company is financially very strong.

Activities and products of the target company

The company is looking for a well established, mid-size company, operating in the generics marketing and sales industry. The buyer would prefer if the target had a presence in Rx as well as OTC segment. The target must have its own sales, marketing, and logistics supply chain management team. It would be preferred if the company had its own sales & marketing set up, QP and logistics in-house. Also, it would be of highly appreciated if the company had its own marketing authorizations granted.

Geographically, the company can be from any country in Europe, but preferably in larger countries such as Germany, France, Spain, Italy, the UK etc. The target should have a stable or growing revenue between 5 – 25M EUR and have a positive yearly EBITDA in the last years. The valuation will be a subject of discussion, the acquisition would be financed from its own funds.

The buyer company has already made an acquisition – outside of Europe in the recent past. The acquisition would help the target company mainly with an expansion of its presence in more geographies and vertical integration. The target would be implemented under a strong brand and financially backed up, if necessary.

Highlights of this generic pharma company wanted in Europe

• The buyer is a leading generics and APIs manufacturing company in India
• The buyer is financially very stable and strong, able to finance the acquisition of its own funds
• The target should preferably be a mid-sized company, preferably with all authorizations and certifications

More information on this generic pharma sales and marketing company wanted in Europe

Please get in touch if you are interested in learning more about this generic pharma sales and marketing company wanted in Europe. For more pharma companies for sale please visit the section pharma companies for sale. For other pharma buyers, please visit the section pharma companies wanted. If you are instead interested in pharma companies for sale, please visit the pharma companies for sale section. For pharma buyers, please visit the section pharma companies wanted.